|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
9,390,000 |
Market
Cap: |
24.70(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$2.18 - $6 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Biostage is a biotechnology company developing bioengineered organ implants based on its Cellframe and and Cellspan technology. Co.'s technology is comprised of a biocompatible scaffold, which is the foundation of its Cellframe technology, that is seeded with the patient's own mesenchymal stromal cells to form its Cellspan implant. Co.'s platform technology is being developed to treat life-threatening conditions of the esophagus, bronchus and trachea. Products being developed based on its technology for those indications are called Cellspan products. Co.'s primary research and development activities are focused in three areas: materials science, cell biology and engineering.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
2,700 |
24,864 |
87,364 |
Total Buy Value |
$0 |
$12,852 |
$113,394 |
$488,394 |
Total People Bought |
0 |
1 |
2 |
3 |
Total Buy Transactions |
0 |
1 |
7 |
8 |
Total Shares Sold |
0 |
0 |
0 |
134,295 |
Total Sell Value |
$0 |
$0 |
$0 |
$962,849 |
Total People Sold |
0 |
0 |
0 |
4 |
Total Sell Transactions |
0 |
0 |
0 |
4 |
End Date |
2024-03-21 |
2023-12-19 |
2023-06-20 |
2022-06-20 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Dst Capital Llc |
10% Owner |
|
2018-01-17 |
4 |
B |
$2.20 |
$11,000 |
I/I |
5,000 |
10,450 |
1.5 |
- |
|
Dst Capital Llc |
10% Owner |
|
2018-01-12 |
4 |
B |
$2.16 |
$10,800 |
I/I |
5,000 |
5,450 |
1.5 |
- |
|
Dst Capital Llc |
10% Owner |
|
2018-01-11 |
4 |
B |
$1.90 |
$380 |
I/I |
200 |
450 |
1.42 |
- |
|
La Francesca Saverio |
President and CMO |
|
2017-08-24 |
4 |
B |
$0.37 |
$37,000 |
D/D |
100,000 |
293,998 |
2.81 |
- |
|
La Francesca Saverio |
President and CMO |
|
2017-08-23 |
4 |
B |
$0.32 |
$48,000 |
D/D |
150,000 |
193,998 |
2.81 |
- |
|
Dersimonian Harout |
Chief Scientific Officer |
|
2016-10-12 |
4 |
B |
$0.91 |
$9,100 |
D/D |
10,000 |
10,000 |
2.74 |
- |
|
Kennedy John F |
Director |
|
2016-08-26 |
4 |
B |
$0.93 |
$15,033 |
D/D |
16,182 |
58,406 |
2.39 |
- |
|
Mcgorry James Joseph |
President and CEO |
|
2016-08-25 |
4 |
B |
$0.96 |
$24,000 |
D/D |
25,000 |
126,300 |
2.81 |
- |
|
Mcgorry James Joseph |
President and CEO |
|
2016-06-21 |
4 |
B |
$1.07 |
$21,400 |
D/D |
20,000 |
101,300 |
2.81 |
- |
|
Robinson Thomas H |
Director |
|
2016-06-13 |
4 |
B |
$1.17 |
$37,475 |
D/D |
32,000 |
50,000 |
2.39 |
- |
|
Canepa John J |
Director |
|
2016-05-25 |
4 |
B |
$1.46 |
$25,172 |
D/D |
17,241 |
17,241 |
2.39 |
- |
|
Kennedy John F |
Director |
|
2016-05-20 |
4 |
B |
$1.56 |
$10,139 |
D/D |
6,500 |
42,224 |
2.39 |
- |
|
Mcnaughton Thomas |
Chief Financial Officer |
|
2016-05-20 |
4 |
B |
$1.55 |
$7,775 |
D/D |
5,000 |
206,128 |
2.74 |
- |
|
Mcgorry James Joseph |
President and CEO |
|
2016-05-20 |
4 |
B |
$1.56 |
$15,600 |
D/D |
10,000 |
81,300 |
2.81 |
- |
|
Robinson Thomas H |
Director |
|
2016-05-19 |
4 |
B |
$1.36 |
$24,401 |
D/D |
18,000 |
18,000 |
2.39 |
- |
|
La Francesca Saverio |
Chief Medical Officer |
|
2015-12-17 |
4 |
B |
$2.01 |
$4,817 |
D/D |
2,393 |
43,998 |
2.66 |
- |
|
La Francesca Saverio |
Chief Medical Officer |
|
2015-12-17 |
4 |
S |
$1.93 |
$4,615 |
D/D |
(2,393) |
41,605 |
|
- |
|
La Francesca Saverio |
Chief Medical Officer |
|
2015-12-01 |
4 |
B |
$3.01 |
$30,052 |
D/D |
10,000 |
43,998 |
2.74 |
- |
|
Kennedy John F |
Director |
|
2015-12-01 |
4 |
B |
$2.95 |
$26,525 |
D/D |
9,000 |
35,724 |
2.39 |
- |
|
Mcnaughton Thomas |
Chief Financial Officer |
|
2015-11-19 |
4 |
B |
$1.70 |
$17,000 |
D/D |
10,000 |
201,128 |
2.74 |
- |
|
Mcgorry James Joseph |
President and CEO |
|
2015-11-19 |
4 |
B |
$1.79 |
$17,900 |
D/D |
10,000 |
71,300 |
2.81 |
- |
|
Mcnaughton Thomas |
Chief Financial Officer |
|
2015-11-18 |
4 |
B |
$1.56 |
$15,600 |
D/D |
10,000 |
191,128 |
2.74 |
- |
|
Mcnaughton Thomas |
Chief Financial Officer |
|
2015-11-17 |
4 |
B |
$1.32 |
$19,800 |
D/D |
15,000 |
181,128 |
2.74 |
- |
|
Green David |
Director |
|
2015-11-17 |
4 |
B |
$1.34 |
$33,500 |
D/D |
25,000 |
313,259 |
2.39 |
- |
|
La Francesca Saverio |
Chief Medical Officer |
|
2015-09-18 |
4 |
B |
$1.28 |
$12,210 |
D/D |
9,500 |
33,998 |
2.74 |
- |
|
100 Records found
|
|
Page 3 of 4 |
|
|